Relay Therapeutics, Inc.
RLAY
$3.15
-$0.11-3.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -76.00M | -88.11M | -92.21M | -81.39M | -83.50M |
| Total Depreciation and Amortization | 1.33M | 1.37M | 1.37M | 1.40M | 1.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.35M | 19.31M | 12.17M | 21.69M | 13.53M |
| Change in Net Operating Assets | 1.45M | -7.65M | 12.84M | 7.98M | -20.60M |
| Cash from Operations | -57.87M | -75.08M | -65.83M | -50.32M | -89.19M |
| Capital Expenditure | 0.00 | -227.00K | -11.00K | -1.78M | -118.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.00M | -125.94M | 45.56M | 12.31M | 59.80M |
| Cash from Investing | 29.00M | -126.16M | 45.55M | 10.53M | 59.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 800.00K | 218.89M | 1.54M | 48.92M | 21.92M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 800.00K | 218.89M | 1.54M | 48.92M | 21.92M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.07M | 17.64M | -18.74M | 9.13M | -7.59M |